A stratified multi-arm Phase 2 study evaluating the efficacy and safety of LDE225 in patients with advanced/metastatic sarcomas

Trial Profile

A stratified multi-arm Phase 2 study evaluating the efficacy and safety of LDE225 in patients with advanced/metastatic sarcomas

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 21 Jun 2016

At a glance

  • Drugs Sonidegib (Primary)
  • Indications Chondrosarcoma; Ewing's sarcoma; Osteosarcoma; Rhabdomyosarcoma; Soft tissue sarcoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Jun 2016 Status changed from not yet recruiting to active, no longer recruiting.
    • 05 Jun 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top